Skip to content
HowShorted

How shorted is Evofem Biosciences, Inc.? EVFM

10.62%
of shares outstanding reported short · settlement date 29 Apr 2022
vs previous report
+0.02
5 reports (~10 weeks)
−5.10
days to cover
5.05
Aggregate net short position time series for Evofem Biosciences, Inc.

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Evofem Biosciences, Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
3 Mar 202212.21% 28 Feb 202211.23% 15 Mar 2022−0.98
19 Jan 202216.41% 14 Jan 202215.88% 31 Jan 2022−0.53
15 Nov 202117.45% 29 Oct 202115.01% 30 Nov 2021−2.44
20 Oct 202117.75% 15 Oct 202117.45% 29 Oct 2021−0.30
11 Aug 202127.46% 30 Jul 202117.93% 13 Aug 2021−9.53
6 May 202111.75% 30 Apr 202111.14% 14 May 2021−0.61
4 Mar 202111.57% 26 Feb 202110.99% 15 Mar 2021−0.58
9 Nov 20209.16% 30 Oct 20209.62% 13 Nov 2020+0.46

Fails to deliver

The SEC's fails-to-deliver figure for EVFM: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
11,618
17 Jun 2026
Highest in window
127,913
7 Nov 2025
Days with a balance
27
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Evofem Biosciences, Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 128K shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Share on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare · By year: 2019 · 2020 · 2021 · 2022

History

Full reported short interest history
Settlement dateShort %Change
29 Apr 202210.62%+0.02
14 Apr 202210.60%+0.29
31 Mar 202210.31%−0.92
15 Mar 202211.23%−0.98
28 Feb 202212.21%−3.51
15 Feb 202215.72%−0.16
31 Jan 202215.88%−0.53
14 Jan 202216.41%+0.83
31 Dec 202115.58%+0.51
15 Dec 202115.07%+0.06
30 Nov 202115.01%−1.34
15 Nov 202116.35%−1.10
29 Oct 202117.45%−0.30
15 Oct 202117.75%−0.12
30 Sep 202117.87%−0.42
15 Sep 202118.29%+0.97
31 Aug 202117.32%−0.61
13 Aug 202117.93%−9.53
30 Jul 202127.46%+0.16
15 Jul 202127.30%−0.62
30 Jun 202127.92%+3.70
15 Jun 202124.22%+13.70
28 May 202110.52%−0.62
14 May 202111.14%−0.61
30 Apr 202111.75%−3.10
15 Apr 202114.85%+3.50
31 Mar 202111.35%+0.36
15 Mar 202110.99%−0.58
26 Feb 202111.57%−0.04
12 Feb 202111.61%−0.09
29 Jan 202111.70%−1.09
15 Jan 202112.79%−1.59
31 Dec 202014.38%+2.60
15 Dec 202011.78%+2.86
30 Nov 20208.92%−0.70
13 Nov 20209.62%+0.46
30 Oct 20209.16%−1.63
15 Oct 202010.79%−3.73
30 Sep 202014.52%−1.54
15 Sep 202016.06%+9.37
31 Aug 20206.69%+2.18
14 Aug 20204.51%−0.16
31 Jul 20204.67%−2.26
15 Jul 20206.93%+1.96
30 Jun 20204.97%+1.21
15 Jun 20203.76%−3.95
29 May 20207.71%+2.53
15 May 20205.18%+0.87
30 Apr 20204.31%+1.09
15 Apr 20203.22%+0.58
31 Mar 20202.64%+0.05
13 Mar 20202.59%+0.42
28 Feb 20202.17%+0.14
14 Feb 20202.03%+0.18
31 Jan 20201.85%+0.15
15 Jan 20201.70%+0.12
31 Dec 20191.58%−0.03
13 Dec 20191.61%−0.07
29 Nov 20191.68%+0.15
15 Nov 20191.53%−0.05
31 Oct 20191.58%−0.04
15 Oct 20191.62%−1.18
12 Jan 20182.80%+0.24
29 Dec 20172.56%–

Newest first. Scroll inside the table for earlier dates, back to 29 Dec 2017.

Frequently asked questions

How shorted is Evofem Biosciences, Inc. right now?
10.62% of Evofem Biosciences, Inc.'s (EVFM) shares outstanding were reported short for settlement date 29 Apr 2022, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this EVFM's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is EVFM's days to cover?
5.05 days for settlement date 29 Apr 2022: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.